• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$4.61 $0.09 (1.99%)

REAL-TIME: Last trade at

Sangamo Biosciences, Inc.

NASDAQ:SGMO

Jump to this page for:

Related Resources

Revenues Rise at Shire - Analyst Blog

4/27/2012 by Nasdaq

Shire to Buy Pervasis Therapeutics - Analyst Blog

4/18/2012 by Nasdaq

Big Profits in Microcaps that Measure Up

4/12/2012 by Nasdaq

Big Profits in Microcaps that Measure Up

4/12/2012 by Nasdaq

Shire to Buy FerroKin BioSciences - Analyst Blog

3/22/2012 by Nasdaq

Three Cinderella Stocks Ready for the Big Dance

3/19/2012 by Minyanville

Sangamo Presents Functional Cure For HIV/AIDS (SGMO)

3/8/2012 by 247wallst

Shire and Sangamo Cut a Deal - Analyst Blog

2/7/2012 by Nasdaq

Sangamo BioSciences To Partner With Shire To Develop DNA Technology

2/1/2012 by Smart Money

Smart Money Picks: Biotech Stocks With Bullish Short Trends

12/8/2011 by DailyFinance

Rebound Candidates: Stocks Near Lows with Short Covering and Institutional Buying

11/9/2011 by Nasdaq

Rebound Candidates: Stocks Near Lows With Short Covering and Institutional Buying

11/7/2011 by DailyFinance

Brain Disorders: 3 Biotech Stocks at the Forefront

10/5/2011 by Nasdaq

Why Did My Stock Just Die?

10/4/2011 by DailyFinance

Sangamo Neuropathy Drug Failed to Meet Goal in Mid-Stage Trial

10/3/2011 by Fox Business

Sangamo Dropping on Diabetic Drug Failure

10/3/2011 by Minyanville

Mid-Day Update: Stocks Fall as Greece Concerns Outweigh Economic Uptick

10/3/2011 by Nasdaq

About That Developing Technology...

10/3/2011 by DailyFinance

Stocks Choppy; U.S. Manufacturing Data Show Modest Gains, Greece Weighs

10/3/2011 by Nasdaq

Are HIV Drugmakers Doomed?

9/29/2011 by DailyFinance

Sangamo Drops After Positive HIV Drug Study

9/19/2011 by Minyanville

Sangamo Touts Cure for HIV

9/16/2011 by Minyanville

Wall Street's Buy List

8/29/2011 by DailyFinance

Sangamo BioSciences' CEO Discusses Q2 2011 Results - Earnings Call Transcript

7/27/2011 by Seeking Alpha Transcripts

UPDATE: Drug Firms, US Academia To Partner On HIV Projects

7/11/2011 by Smart Money

Sangamo BioSciences CEO Discusses Q1 2011 Results - Earnings Call Transcript

4/26/2011 by Seeking Alpha

Sangamo BioSciences CEO Discusses Q1 2011 Results - Earnings Call Transcript

4/26/2011 by Seeking Alpha Transcripts

Sangamo Biosciences' Game Changing Technology

4/20/2011 by Seeking Alpha

Sangamo Biosciences's Game Changing Technology

4/20/2011 by Seeking Alpha

Squeeze Ideas: 17 Short Seller Targets for a Watchlist

4/1/2011 by Seeking Alpha

Future Biotech Superstars

3/30/2011 by Seeking Alpha

Sangamo (SGMO): An HIV Treatment Speculation

3/11/2011 by BloggingStocks

Sangamo: The Next Pinnacle in HIV Treatment?

3/8/2011 by Seeking Alpha

Sangamo: The Next Pinnacle in HIV Treatment?

3/8/2011 by Seeking Alpha

Squeeze Ideas: 20 Biotech Stocks Targeted by Short Sellers

3/3/2011 by Seeking Alpha

Sangamo BioSciences CEO Discusses Q4 2010 Results - Earnings Call Transcript

2/2/2011 by Seeking Alpha Transcripts

Sangamo BioSciences CEO Discusses Q4 2010 Results - Earnings Call Transcript

2/2/2011 by Seeking Alpha

Sangamo BioSciences' Platform Could Be the Future of Biotech

2/1/2011 by Seeking Alpha

18 Small Cap Stocks Targeted by Short Sellers

1/18/2011 by Seeking Alpha

Sangamo BioSciences CEO Discusses Q3 2010 Results – Earnings Call Transcript

10/31/2010 by Seeking Alpha
See More Articles...